4Schaloske RH,Dennis EA.The phospholipaseA2superfamily and itsgroup numbering system[J].Bilchim Biophys Acta,2006,1761:1246-1259.
5Tselepis AD,John Chapman M.Inflammation,bioactive lipids andatherosclerosis:potential roles of a lipoprotein-associated phospho-lipase A2,platelet activating factor-acetylhydrolase[J].Athero-scler,2002,51:57-68.
6Dupuis F,Denizor Y,Fixe P,et al.PAF and haematopoiesis.X.Mar-cophage colony-stimulating factor and granulocyte macrophage col-onying-stimulating factor enhance platelet-activating factor acetyl-hydrolase production by human blood-derived macrophages[J].Biochim Biophys Acta,1996,1311:27-32.
7Watanabe J,Marathe GK,Neilsen PO.Endotoxins stimulate neutro-phil adhesion followed by synthesis and release of platelet-activa-ting factor in micropaticles[J].J Biol Chem,2003,278:33161-33168.
8Blake GJ,Dada N,FoxJC,et al.A prospective evaluation of lipopro-tein-associated phospholipaseA(2)levels and the risk of futurecardiovascular events in women[J].J AM Coll Cardiol,2001,38:1302-1306.
9Winker K,Winkelmann BR,Scharnag1 H,et al.Platelet-activatingfactor acetylhydrolase activity indicates angiographic coronary arterydisease independently of systemic inflammation and other risk fac-tors:the Ludwigshafen Risk and Cardiovascular Health Study[J].Circulation,2005,111(8):980-987.
10Hakkinen T,Luoma JS,Hiltunen MO,et al.Platelet-activatingfactor acetylhydrolase,is expressed by macrophages in human andrabbit atherosclerotic lesions[J].Arterioscler Thromb Vasc Biol,1997,19:2909-2917.
4Wei HH, van der Meer IM, Hofman A, et al. Lipoprotein-associat- ed phospholipase A2 activity is associated with risk of coronary heart disease and ischemic stroke :the Rotterdam Study [J]. Circu- lation, 2005,111(5):70.
5Winkler K, Hoffmann MM, Winkelmann BR, et al. Lipoprotein-as- soeiated phospholipase A2 predicts 5-year cardiac mortality inde- pendently of established risk factors and adds prognostic informa- tion in patients with low and medium high-sensitivity C-reactive protein[J]. Clin Chem,2007,53(8):440.
6Caslake MJ, Packard C J, Suckling KE, et al. Lipoprotein-associat- ed phospholipase A2, platelet-activating factor acetylhydrolase: a potential new risk factor for coronary artery disease[J]. Atheroscle- rosis, 2000,150:413-419.
7Telis CC, Tselepis AD. The role of lipoprotein-associated phos- pholipase A2 in atherosclerosis may depend on its lipoprotein car- tier in plasma[J]. Biochim Biophys Acta, 2009,1791(5):327-338.
8Zalewski A, Macphee C, Nelson JJ. Lipoprotein-associated phus- pholipase A2: apotential therapeutic target for atherosclerosis [J]. Curr Drug Targets Cardiovasc Haemaol Disord, 2005,5(6):527-532.
9Kolodgie FD, Burke AP, Skorija KS, et al. Lipoprotein-assuciated phospholipase A2 protein expression in the natural progression of human corocary atherosclerosis [J]. Artreiosclre Thromb Vasc Biol, 2006, 26(11):2523-2529.
10Caslake MJ, Packard CJ, Suckling KE, et al. Lipoprotein-associ- ated phospholipase A2, platelet activating factor acetylhydrolase: Apotential new risk factor for coronary artery disease [J]. Atherosclerosis, 2000,150(2):413-419.
